Impact of Mobile Health Interactive Software on Tuberculosis Outcomes; The Call for Life (CFLU-TB) Project
Condition:   Tuberculosis Intervention:   Other: Call for Life Uganda Sponsor:   Infectious Diseases Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2021 Category: Research Source Type: clinical trials

Treatment Success and Safety of 4 Weeks of Daily Rifapentine and Isoniazid (1HP) vs. 12 Weeks of Weekly Rifapentine and Isoniazid (3HP) for Prevention of Tuberculosis in HIV-uninfected Individuals (1v3HP for TPT in HIV-uninfected Individuals)
Condition:   Tuberculosis Interventions:   Drug: Rifapentine 600 mg and INH 300 mg;   Drug: Rifapentine 900 mg and INH 900 mg Sponsors:   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2021 Category: Research Source Type: clinical trials

Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
Conditions:   TB - Tuberculosis;   HIV/AIDS Intervention:   Sponsors:   University of Stellenbosch;   New York University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2021 Category: Research Source Type: clinical trials

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: rifampicin;   Drug: pyrazinamide;   Drug: HRZE;   Drug: HR Sponsors:   University Hospital, Linkoeping;   Karolinska University Hospital;   Ryhov County Hospital;   Kalmar County Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2021 Category: Research Source Type: clinical trials

DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE)
Conditions:   Tuberculosis, Pulmonary;   HIV Seropositivity Interventions:   Device: Tor Vergata Electronic Nose (TV eNose);   Other: Survey & Physical Exam;   Diagnostic Test: TB LAMP test;   Other: Sputum Samples;   Other: Chest X-Ray;   Other: Follow Up 5 days after beginning of Tx.;   Other: Follow Up & 15 days after beginning of Tx.;   Other: Follow Up & 3...
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials

Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19
Conditions:   Tuberculosis;   Covid19 Intervention:   Other: Impact of respiratory isolation on quality of life Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2020 Category: Research Source Type: clinical trials